Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome
Circulation · 16.12.2025 · 152 (24) · 1666-1678
DOI: 10.1161/circulationaha.125.073855 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Circulation, erschienen am 16.12.2025. Verfasst von Sotirios Tsimikas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Sulpizio Cardiovascular Center, Divisions of Cardiovascular Medicine (S.T.), University of California San Diego, La Jolla, CA. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Apolipoprotein B-100, Lipoprotein(a), Phospholipids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Oxidized phospholipids on apolipoprotein B-100 (OxPL-apoB) reflect pro-inflammatory properties of Lp(a) (lipoprotein(a)). The effect of OxPL-apoB on major adverse cardiovascular events (MACE) in patients with acute coronary syndrome in recent the era is not known. METHODS: OxPL-apoB levels and Lp(a) were measured in 11 630 participants before and 5185 participants 4 months after randomization to alirocumab or placebo in the ODYSSEY OUTCOMES trial. Proportional hazards models adjusted for baseline covariates evaluated associations between log 2 -transformed OxPL-apoB and Lp(a) with MACEs. Interactions between the 2 biomarkers and treatment were also evaluated. RESULTS: Participants were followed for a median 2.9 years; the median age was 58 years, and 23.9% were female. Alirocumab reduced median placebo-adjusted OxPL-apoB by 13.0% and Lp(a) by 26.2% (both P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sulpizio Cardiovascular Center, Divisions of Cardiovascular Medicine (S.T.), University of California San Diego, La Jolla, CA.
- CPC Clinical Research, Aurora, CO (M.S.).
- State University of New York, Downstate Health Sciences University, Brooklyn, NY (M.S.).
- Division of Cardiology, University of Colorado School of Medicine, Aurora, CO (M.S., G.G.S.).
- Departments of Clinical Chemistry and Laboratory Medicine (C.C., F. R.), Leiden University Medical Center, the Netherlands.
- Cardiology (J.W.J.), Leiden University Medical Center, the Netherlands.
ORCID-Profile: Sotirios Tsimikas, Michael Szarek, Christa M Cobbaert, Fred Romijn, J Wouter Jukema, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Sergio Fazio, Genevieve Garon, Shaun G Goodman, Harvey D White, Joseph L Witztum, P Gabriel Steg, Gregory G Schwartz
Zitieren
APA
Tsimikas, S., Szarek, M., Cobbaert, C. M., Romijn, F., Jukema, J. W., Bhatt, D. L., Bittner, V. A., Diaz, R., Fazio, S., Garon, G., Yuan, C., Gong, X. M., Goodman, S. G., White, H. D., Witztum, J. L., Steg, P. G., Schwartz, G. G., & ODYSSEY OUTCOMES Investigators (2025). Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome. Circulation, 152(24), 1666-1678. https://doi.org/10.1161/circulationaha.125.073855
Vancouver
Tsimikas S, Szarek M, Cobbaert CM, Romijn F, Jukema JW, Bhatt DL, et al. Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome. Circulation. 2025;152(24):1666-1678. doi:10.1161/circulationaha.125.073855
BibTeX
@article{Tsimikas2025,
author = {Tsimikas, Sotirios and Szarek, Michael and Cobbaert, Christa M and Romijn, Fred and Jukema, J Wouter and Bhatt, Deepak L and Bittner, Vera A and Diaz, Rafael and Fazio, Sergio and Garon, Genevieve and Yuan, Chong and Gong, Xiao-Min and Goodman, Shaun G and White, Harvey D and Witztum, Joseph L and Steg, P Gabriel and Schwartz, Gregory G and ODYSSEY OUTCOMES Investigators, ODYSSEY OUTCOMES Investigators},
title = {Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome},
journal = {Circulation},
year = {2025},
volume = {152},
number = {24},
pages = {1666--1678},
doi = {10.1161/circulationaha.125.073855}
}
EUVIMED